A detailed history of Mba Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Mba Advisors LLC holds 12,056 shares of PFE stock, worth $322,377. This represents 0.17% of its overall portfolio holdings.

Number of Shares
12,056
Previous 15,122 20.28%
Holding current value
$322,377
Previous $423,000 17.73%
% of portfolio
0.17%
Previous 0.22%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$27.7 - $31.39 $84,928 - $96,241
-3,066 Reduced 20.28%
12,056 $348,000
Q2 2024

Jul 30, 2024

SELL
$25.26 - $29.6 $17,985 - $21,075
-712 Reduced 4.5%
15,122 $423,000
Q1 2024

Apr 26, 2024

SELL
$25.89 - $29.73 $1,889 - $2,170
-73 Reduced 0.46%
15,834 $439,000
Q4 2023

Jan 19, 2024

SELL
$26.13 - $33.94 $31,826 - $41,338
-1,218 Reduced 7.11%
15,907 $457,000
Q3 2023

Oct 19, 2023

BUY
$32.09 - $37.51 $16,237 - $18,980
506 Added 3.04%
17,125 $568,000
Q2 2023

Jul 21, 2023

SELL
$36.12 - $41.79 $21,888 - $25,324
-606 Reduced 3.52%
16,619 $609,000
Q1 2023

Apr 20, 2023

BUY
$39.39 - $51.28 $2,048 - $2,666
52 Added 0.3%
17,225 $702,000
Q4 2022

Jan 25, 2023

BUY
$41.75 - $54.5 $4,258 - $5,559
102 Added 0.6%
17,173 $0
Q3 2022

Oct 31, 2022

BUY
$43.76 - $53.42 $87 - $106
2 Added 0.01%
17,071 $747,000
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $418 - $496
9 Added 0.05%
17,069 $895,000
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $57,187 - $70,862
-1,250 Reduced 6.83%
17,060 $883,000
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $148,090 - $219,520
3,584 Added 24.34%
18,310 $1.08 Million
Q3 2021

Nov 16, 2021

BUY
$39.25 - $50.42 $7,536 - $9,680
192 Added 1.32%
14,726 $633,000
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $4,919 - $5,573
137 Added 0.95%
14,534 $569,000
Q1 2021

May 18, 2021

BUY
$33.49 - $37.77 $482,155 - $543,774
14,397 New
14,397 $522,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mba Advisors LLC Portfolio

Follow Mba Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mba Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mba Advisors LLC with notifications on news.